If Sud Capital Gestion, in Marseille, wasn't much present in the financing of start-ups of Sophia, however, this company of venture capital has just invested about ten million francs in CLL Pharma, a company from Nice specialised in the creation of generic drugs. Set up in 1995 by Claude Laruelle, former researcher of the human medicine departments of Virbac and Arkopharma, CLL Pharma (about thirty people) was seeking funds for its development and grouping on Sophia Antipolis. The company plans a listing on the stock exchange for next autumn.
